GB1152674A - Improvements in or relating to the Prevention of Maturation of Spermatogenesis - Google Patents

Improvements in or relating to the Prevention of Maturation of Spermatogenesis

Info

Publication number
GB1152674A
GB1152674A GB52246/66A GB5224666A GB1152674A GB 1152674 A GB1152674 A GB 1152674A GB 52246/66 A GB52246/66 A GB 52246/66A GB 5224666 A GB5224666 A GB 5224666A GB 1152674 A GB1152674 A GB 1152674A
Authority
GB
United Kingdom
Prior art keywords
spermatogenesis
maturation
prevention
suspensions
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB52246/66A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commercial Solvents Corp
Original Assignee
Commercial Solvents Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commercial Solvents Corp filed Critical Commercial Solvents Corp
Publication of GB1152674A publication Critical patent/GB1152674A/en
Expired legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1,152,674. Prevention of spermatogenesis maturation. COMMERCIAL SOLVENTS CORP. 22 Nov., 1966 [7 Dec., 1965], No. 52246/66. Heading A5B. A pharmaceutical preparation in dosage unit form for use in inhibiting spermatogenesis in male mammals from progressing to the free sperm stage comprises 1.0 to 500 mg. of a compound having the structural .formula in admixture with a non-toxic, pharmaceutically-acceptable carrier therefor. Administration may be orally in the form of tablets, capsules, pills, syrups, solutions, suspensions, dispersible powders or mixtures with animal foodstuffs; or parenterally e.g. in the form of sterile aqueous solutions or suspensions ; in oily media, the various forms containing conventional excipients.
GB52246/66A 1965-12-07 1966-11-22 Improvements in or relating to the Prevention of Maturation of Spermatogenesis Expired GB1152674A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51224165A 1965-12-07 1965-12-07

Publications (1)

Publication Number Publication Date
GB1152674A true GB1152674A (en) 1969-05-21

Family

ID=24038274

Family Applications (1)

Application Number Title Priority Date Filing Date
GB52246/66A Expired GB1152674A (en) 1965-12-07 1966-11-22 Improvements in or relating to the Prevention of Maturation of Spermatogenesis

Country Status (4)

Country Link
BE (1) BE690837A (en)
FR (1) FR6898M (en)
GB (1) GB1152674A (en)
IL (1) IL26902A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016254A2 (en) * 2002-08-16 2004-02-26 Immugen Pharmaceuticals, Inc. Contraceptive methods and formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004016254A2 (en) * 2002-08-16 2004-02-26 Immugen Pharmaceuticals, Inc. Contraceptive methods and formulations
WO2004016254A3 (en) * 2002-08-16 2004-04-15 Immugen Pharmaceuticals Inc Contraceptive methods and formulations

Also Published As

Publication number Publication date
BE690837A (en) 1967-05-16
FR6898M (en) 1969-04-28
IL26902A (en) 1970-06-17

Similar Documents

Publication Publication Date Title
GB1221393A (en) Improvements in or relating to hepato-protective drugs
GB1054104A (en)
GB1152674A (en) Improvements in or relating to the Prevention of Maturation of Spermatogenesis
GB1152677A (en) Improved Anabolic Agent
GB1252286A (en)
GB1152676A (en) Improvements in or relating to the Prevention of Pregnancy
GB1256723A (en)
GB1049996A (en) New medicine with anti-inflammatory and anti-rheumatic activity
GB1393451A (en) Pharmaceutical compositions containing a 1-phenoxy-3-alkoxy- 2-propanol
GB1126153A (en) Novel polygalacturonic acid derivative
GB1298587A (en) Methods of contraception and contraceptive compositions
GB1091109A (en) New derivative of phenylbutazone and its preparation
JPS5498791A (en) Anti-asthmatic drug
GB911179A (en) Hypnotic and tranquilizing compositions comprising 4, 6-dimethyl-3-pyridazone
GB1147612A (en) Compositions for the treatment of peptic ulcers
GB1280244A (en) Serum triglyceride-lowering compositions
GB1089189A (en) Ethers of -(2-pyridyl)benzyl alcohols
GB1220793A (en) Pharmaceutical compositions
GB1024491A (en) Succinimide derivatives and their preparation
JPS5788119A (en) Antitumor agent
GB860940A (en) New diphenyl derivative
GB1174187A (en) Compositions with an Activitiy Against Protozoa
ES356496A1 (en) 2-amino-3-carbamido-quinoxaline-di-n-oxides and their production
GB1099269A (en) New anti-arteriosclerotic compositions
GB1159646A (en) N-(2-Alkenyl)-Azabicyclo-Octanes and Nonanes

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
PLNP Patent lapsed through nonpayment of renewal fees